SCHEMBL1629643

SCHEMBL1629643

COc1cc(OC)c(S(=O)(=O)Cl)cc1-c1ccnn1-c1ccccc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 2/20 0.39
HSP90AA1 P07900 2/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
HIF1A Q16665 1/20 0.37
TRPV4 Q9HBA0 1/20 0.36
PDE10A Q9Y233 2/20 0.35
MAPK14 Q16539 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
POLB P06746 1/20 0.33
SLC16A3 O15427 1/20 0.33
SLC16A1 P53985 1/20 0.33
CYP17A1 P05093 1/20 0.33
CYP1A2 P05177 1/20 0.33
HSD11B1 P28845 1/20 0.32
KDM5A P29375 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629805 0.89 NR3C2 (0.41) NR3C2HSP90AA1ALDH1A1KDM4ELMNA
SCHEMBL1219165 0.89 HSP90AA1 (0.40) NR3C2HSP90AA1ALDH1A1LMNATP53
SCHEMBL1628808 0.86 ALDH1A1 (0.42) NR3C2HSP90AA1ALDH1A1KDM4ELMNA
SCHEMBL27675323 0.85 NR3C2 (0.37) NR3C2HSP90AA1ALDH1A1LMNATP53
SCHEMBL12722754 0.85 PDE10A (0.49) ALDH1A1LMNATRPV4PDE10AMAPT
SCHEMBL1628681 0.84 ALPL (0.47) ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL1631535 0.84 TSHR (0.46) NR3C2HSP90AA1ALDH1A1KDM4ETP53
SCHEMBL1630540 0.82 CYP1A2 (0.53) ALDH1A1LMNASMN1; SMN2CYP1A2
SCHEMBL1629242 0.81 HSP90AA1 (0.46) NR3C2HSP90AA1ALDH1A1KDM4ELMNA
SCHEMBL1219068 0.80 HSP90AA1 (0.45) NR3C2HSP90AA1ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P NR3C2 558/4885HSP90AA1 2/4885ALDH1A1 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.